CRISPR Reverses Chemo Resistance in Lung Cancer
CRISPR technology reverses chemotherapy resistance in lung cancer by disabling the NRF2 gene. This improves drug sensitivity and slows tumor growth, offering a novel strategy for resistant cancers.
CRISPR technology reverses chemotherapy resistance in lung cancer by disabling the NRF2 gene. This improves drug sensitivity and slows tumor growth, offering a novel strategy for resistant cancers.